Avrobio Inc. (AVRO) PT Lowered to $3 at Morgan Stanley

Go back to Avrobio Inc. (AVRO) PT Lowered to $3 at Morgan Stanley

Avrobio Inc. (AVRO) PT Lowered to $6 at Mizuho Securities

January 5, 2022 5:28 PM EST

Mizuho Securities analyst Uy Ear lowered the price target on Avrobio Inc. (NASDAQ: AVRO) to $6.00 (from $28.00) while maintaining a Buy rating.

The analyst commented, "The new clinical data from the Fabry program is disappointing. We update our model to exclude our sales and... More